Anlon Healthcare IPO Subscription Status

Anlon Healthcare IPO Subscription Status
Anlon Healthcare IPO subscription started on 26 August, 2025 and will close on 29 August, 2025. The retail quota is 10%, QIB is 75% and NII is 15%. Anlon Healthcare IPO got a lot of interest, raising around ₹1,33,00,000 shares (aggregating up to ₹121.03 Cr) Crores, with subscriptions [.] times overall, including [.] times by institutional investors, [.] times by non-institutional investors, and [.] times by retail investors. Shares are priced between ₹₹86 to ₹91 per share each and will be listed on the BSE and NSE.
  Check Live IPO  Subscription List  👈
Upcoming
Last Updated - [.]

Anlon Healthcare IPO Subscription - Day [.]

QIB - Qualified Institutional Buyers: [.]x
NII - Non-Institutional Investors: [.]x
SNII - Small Non-Institutional Investors: [.]x
BNII - Big Non-Institutional Investors: [.]x
RII - Retail Individual Investor: [.]x
Total: [.]x 👈

Anlon Healthcare IPO Investor Categories

  • Qualified Institutional Buyers: QIB
  • Non-Institutional Investors: NII
  • Small Non-Institutional Investors: SNII- Bid below ₹10L
  • Big Non-Institutional Investors: BNII- Bid above ₹10L
  • Retail Individual Investor: RII
  • Employees Quota: EMP

Anlon Healthcare IPO Dates

IPO Activity Date
Open Date: 26 August, 2025
Close Date: 29 August, 2025
Allotment Date: 1 September, 2025
Refund Date: 2 September, 2025
Shares Credit Date: 2 September, 2025
Listing Date: 3 September, 2025

Anlon Healthcare IPO Subscription Status FAQs

Q.When Anlon Healthcare IPO Subscription will start?

Ans.The IPO subscription starts on 26 August, 2025 for Investors.


Q.What is the Anlon Healthcare IPO Subscription last date?

Ans.Anlon Healthcare IPO subscription last date is 29 August, 2025 for Investors.


Q.What is the Anlon Healthcare IPO Allotment Date?

Ans.Anlon Healthcare IPO allotment date is 1 September, 2025.


Q.What is the Anlon Healthcare IPO Listing Date?

Ans.Anlon Healthcare IPO listing date is 3 September, 2025. The IPO is to list on BSE and NSE.